CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- 4 Planned sale Watanabe Todd sold 4,375 shares at $26.12 ($114,261)
- 4 Grant or award Director acquired 4,315 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 4,730 shares at $26.91 ($127,284)
- 4 Planned sale Director sold 4,946 shares at $24.38 ($120,587)
- 4 Planned sale Director sold 4,731 shares at an average $24.58 ($116,281)
- 4/A Insider Changes in Ownership
- 4 Grant or award Director acquired 5,778 shares (grant or award)
- 4 Grant or award Director acquired 5,778 shares (grant or award)
- 4 Grant or award Director acquired 5,778 shares (grant or award)
- 4 Grant or award Director acquired 5,778 shares (grant or award)
- 4 Grant or award Director acquired 5,778 shares (grant or award)
- 4 Grant or award Director acquired 5,778 shares (grant or award)
- 4 Grant or award Director acquired 5,778 shares (grant or award)
- 4 Grant or award Director acquired 5,778 shares (grant or award)
- 4 Planned sale SVP Chief Financial Officer sold 435 shares at $21.05 ($9,157)
- 4 Planned sale Burnett Patrick sold 222 shares at $21.05 ($4,673)
- 4 Planned sale Matsuda Masaru sold 8,256 shares at an average $23.31 ($192,415)
- 4 Planned sale Burnett Patrick sold 684 shares at $23.61 ($16,150)
- 4 Planned sale SVP Chief Financial Officer sold 1,341 shares at $23.61 ($31,662)
Page 2 of 23 · 452 filings